Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure Control.

Journal of the American Heart Association
Kelsey B BryantBrandon K Bellows

Abstract

Background Self-monitoring of blood pressure (SMBP) improves blood pressure (BP) outcomes at 12-months, but information is lacking on how SMBP affects hypertension care processes and longer-term BP outcomes. Methods and Results We pooled individual participant data from 4 randomized clinical trials of SMBP in the United Kingdom (combined n=2590) with varying intensities of support. Multivariable random effects regression was used to estimate the probability of antihypertensive intensification at 12 months for usual care versus SMBP. Using these data, we simulated 5-year BP control rates using a validated mathematical model. Trial participants were mostly older adults (mean age 66.6 years, SD 9.5), male (53.9%), and predominantly white (95.6%); mean baseline BP was 151.8/85.0 mm Hg. Compared with usual care, the likelihood of antihypertensive intensification increased with both SMBP with feedback to patient or provider alone (odds ratio 1.8, 95% CI 1.2-2.6) and with telemonitoring or self-management (3.3, 2.5-4.2). Over 5 years, we estimated 33.4% BP control (<140/90 mm Hg) with usual care (95% uncertainty interval 27.7%-39.4%). One year of SMBP with feedback to patient or provider alone achieved 33.9% (28.3%-40.3%) BP control a...Continue Reading

References

Oct 25, 2002·American Journal of Epidemiology·Diane E BildRussell P Tracy
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jun 26, 2008·JAMA : the Journal of the American Medical Association·Beverly B GreenRobert S Thompson
May 26, 2010·Hypertension·Alexander TurchinPaul R Conlin
Jul 13, 2011·Archives of Internal Medicine·Hayden B BosworthEugene Z Oddone
Oct 21, 2011·International Journal of Hypertension·S Baral-GrantR J McManus
Dec 7, 2011·Journal of General Internal Medicine·Paul L HebertMary Ann McLaughlin
Apr 24, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Miren I JonesRichard J McManus
Mar 14, 2013·Health Services Research·Jean Marie Abraham
Jun 5, 2013·The Journal of Clinical Hypertension·Nayan DesaiChristopher McFadden
Jun 6, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Miren I JonesRichard J McManus
Jul 4, 2013·JAMA : the Journal of the American Medical Association·Karen L MargolisNicole K Trower
Aug 31, 2013·European Journal of Preventive Cardiology·Billingsley KaambwaRichard J McManus
Mar 13, 2014·Circulation. Cardiovascular Quality and Outcomes·Matthew L MaciejewskiGeorge L Jackson
Oct 27, 2015·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sabrina GrantRichard J McManus
Jul 25, 2017·Journal of the American Society of Hypertension : JASH·Ian M KronishPaul Muntner
Jan 18, 2018·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Anna Beth BartonMatthew J Crowley
May 23, 2018·American Journal of Hypertension·Eileen J CarterIan M Kronish
Jun 22, 2018·The International Journal of Pharmacy Practice·Aleksandra MilosavljevicJeff Harrison

❮ Previous
Next ❯

Software Mentioned

TreeAge
BPCM
STATA
TreeAge Pro
R

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.